The role of de novo mutations in the genetics of autism spectrum disorders
- PMID: 24430941
- DOI: 10.1038/nrg3585
The role of de novo mutations in the genetics of autism spectrum disorders
Abstract
The identification of the genetic components of autism spectrum disorders (ASDs) has advanced rapidly in recent years, particularly with the demonstration of de novo mutations as an important source of causality. We review these developments in light of genetic models for ASDs. We consider the number of genetic loci that underlie ASDs and the relative contributions from different mutational classes, and we discuss possible mechanisms by which these mutations might lead to dysfunction. We update the two-class risk genetic model for autism, especially in regard to children with high intelligence quotients.
Similar articles
-
A framework for the interpretation of de novo mutation in human disease.Nat Genet. 2014 Sep;46(9):944-50. doi: 10.1038/ng.3050. Epub 2014 Aug 3. Nat Genet. 2014. PMID: 25086666 Free PMC article.
-
Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations.Nat Genet. 2011 Jun;43(6):585-9. doi: 10.1038/ng.835. Epub 2011 May 15. Nat Genet. 2011. PMID: 21572417 Free PMC article.
-
Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders.Hum Mol Genet. 2011 Sep 1;20(17):3366-75. doi: 10.1093/hmg/ddr243. Epub 2011 May 30. Hum Mol Genet. 2011. PMID: 21624971 Free PMC article.
-
From de novo mutations to personalized therapeutic interventions in autism.Annu Rev Med. 2015;66:487-507. doi: 10.1146/annurev-med-091113-024550. Annu Rev Med. 2015. PMID: 25587659 Review.
-
Recent progresses in molecular genetics of autism spectrum disorders.Yi Chuan. 2015 Sep;37(9):845-54. doi: 10.16288/j.yczz.15-281. Yi Chuan. 2015. PMID: 26399524 Review.
Cited by
-
Extracellular Vesicles in Neurological Disorders.Subcell Biochem. 2021;97:411-436. doi: 10.1007/978-3-030-67171-6_16. Subcell Biochem. 2021. PMID: 33779926
-
Amplicon Resequencing Identified Parental Mosaicism for Approximately 10% of "de novo" SCN1A Mutations in Children with Dravet Syndrome.Hum Mutat. 2015 Sep;36(9):861-72. doi: 10.1002/humu.22819. Epub 2015 Jul 24. Hum Mutat. 2015. PMID: 26096185 Free PMC article.
-
Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes.Front Cell Neurosci. 2015 Feb 26;9:55. doi: 10.3389/fncel.2015.00055. eCollection 2015. Front Cell Neurosci. 2015. PMID: 25767435 Free PMC article. Review.
-
A systematic variant annotation approach for ranking genes associated with autism spectrum disorders.Mol Autism. 2016 Oct 21;7:44. doi: 10.1186/s13229-016-0103-y. eCollection 2016. Mol Autism. 2016. PMID: 27790361 Free PMC article.
-
Selective Serotonin Reuptake Inhibitor Use during Pregnancy and the Risk of Autism Spectrum Disorders: A Review.J Pediatr Genet. 2015 Jun;4(2):84-93. doi: 10.1055/s-0035-1556744. J Pediatr Genet. 2015. PMID: 27617119 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
